Concepedia

Andrew Jallouk

AJ

10

Publications

412

Citations

10

H-Index

2012

Active since

Affiliations

Washington University in St. Louis(Current)

The University of Texas MD Anderson Cancer Center

University of Pennsylvania

Andrew Jallouk is an author at Washington University in St. Louis specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2012–2024

10

Publications

10

Cytolytic Nanoparticles Attenuate HIV-1 Infectivity

Joshua L. Hood, Andrew Jallouk, Nancy Campbell et al. · Antiviral Therapy · 2012 · 117 citations

NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2024 · 74 citations

Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis

Rohun U Palekar, Andrew Jallouk, Jacob W. Myerson et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2016 · 47 citations · Full text

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

Paolo Strati, Andrew Jallouk, Qing Deng et al. · Blood Advances · 2023 · 38 citations · Full text

, , +12

Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles

Andrew Jallouk, Rohun U Palekar, Jon N. Marsh et al. · Bioconjugate Chemistry · 2015 · 36 citations

, , +16

Rows per page

1–5 of 10